AngioDynamics, Inc. (NASDAQ: ANGO) AI-Powered Stock Analysis
See how AngioDynamics, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
ANGO●NASDAQ
HealthcareMedical - Instruments & Supplies
$13.59
$0.15(1.12%)
U.S. Market opens in 14h 25m
AngioDynamics, Inc. (NASDAQ: ANGO) AI-Powered Stock Analysis
See how AngioDynamics, Inc. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerAngioDynamics, Inc. (NASDAQ: ANGO) Stock Overall Grade
AngioDynamics, Inc.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to AngioDynamics, Inc.'s overall NASDAQ stock rating.
Forecast
B+Score
72/100Financial Growth
BScore
65/100Fundamental Growth
C+Score
51/100Key Ratios
C+Score
57/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
97/100Analyst Consensus
B+Score
75/100AngioDynamics, Inc. (NASDAQ: ANGO) AI-Powered Stock Analysis
On the NASDAQ, ANGO demonstrates Good performance with an overall Forecast Score of 72/100 (B+), reflecting high confidence in its potential. Financial Growth (65/100, B) and Fundamental Growth (51/100, C+) highlight its stability, while Key Ratios (57/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (97/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (75/100, B+) suggests High divergence in outlook.(NASDAQ: ANGO) Component Analysis Explained
Understand the key factors behind each AngioDynamics, Inc. (NASDAQ: ANGO) stock grade, including financials, comparisons, and forecasts.